DCF — AMEND 1 CENTERPOINT MEDICAL CENTER
Enterprise Value: $241.4M
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$241.4M
Enterprise Value
$61.4M
PV of Cash Flows
$180.0M
PV of Terminal Value
$289.8M
Terminal Value
10.0%
WACC
2.5%
Terminal Growth
Cash Flow Projections
PROJ| Year | Revenue | EBITDA | Margin | FCF | PV(FCF) |
|---|---|---|---|---|---|
| Year 1 | $390.1M | $33.2M | 9.0% | $10.8M | $9.8M |
| Year 2 | $401.8M | $38.2M | 10.0% | $14.1M | $11.7M |
| Year 3 | $413.9M | $43.5M | 11.0% | $17.7M | $13.3M |
| Year 4 | $426.3M | $46.9M | 11.0% | $19.8M | $13.5M |
| Year 5 | $439.1M | $49.4M | 11.0% | $21.2M | $13.2M |
Interpretation
INTAt a WACC of 10.0% and terminal growth of 2.5%, enterprise value is $241.4M. Terminal value accounts for 75% of total EV — typical range (60-80%).
Next steps: Check the LBO model to see equity returns at this entry price, or the EBITDA bridge to model value creation levers.
Assumptions
ASSMrevenue base$378.8M
revenue growth rates[0.03, 0.03, 0.03, 0.03, 0.03]
ebitda margin base0.08000000126723332
ebitda margin improvement bps[50, 100, 100, 50, 25]
capex pct revenue0.04
nwc pct revenue0.08
tax rate0.25
projection years5